【Venue】JHVS Stage, Pacifico Yokohama
A variety of events will take place on the JHVS stage in the exhibition hall.
- Oct.9(Wed.) 16:00 ～ 17:00
- JHVS&MEDISO Results Report
- Oct.10(Thu.) 10:00 ～ 11:00
- Human Resources Exchange Program
- Oct.10(Thu.) 11:15 ～ 12:15
- Human Augmentation
- Oct.10(Thu.) 16:00 ～ 17:00
- Oct.11(Fri.) 10:30 ～ 12:00
- Support of the Core Clinical Research Hospitals for Venture Companies
- Oct.11(Fri.) 13:00 ～ 14:10
JHVS&MEDISO Results Report
【Date & Time】 Oct.9(Wed.) 16:00～17:00
Are you interested in the achievements of the medical venture aid projects of the Ministry of Health, Labour and Welfare of Japan, now in its third year? In this session, we will report and analyze the achievements made through the JHVS and MEDISO projects and introduce some of the venture companies. They will introduce how they have become successful through JHVS exhibitions and by support from MEDISO.
Venture Support Strategy Office, Economic Affairs Division,
Health Policy Bureau, Ministry of Health, Labour and Welfare
Human Resources Exchange Program
【Date & Time】 Oct.10(Thu.) 10:00～11:00
This session introduces a collaborative work with Blockbuster TOKYO and the Tokyo Metropolitan Government, an endorsement program for drug discovery and medical ventures in Tokyo. The waves of human resource partnerships have reached the pharma industry and academia as well. Loaned employee and pro bono services, for example, have become common trends in recent years. In this session, we will invite experts from the government, industry and academia and discuss the purpose of human resource partnerships, in more fluid forms, as well as the value for the service providers using real-life examples in order to understand the background and future needs.
【Date & Time】 Oct.10(Thu.) 11:15～12:15
We have added a hands-on product area as a new experiment for this year’s JHVS. We expect to see this area exhibit humanaugmentation products that extend humanity by combining people and technology in an effort to realize a society in which the elderly and disabled can live with peace of mind. The area will offer an excellent opportunity to discover new possibilities through hands-on time with commercialized technologies and stage presentations that explore future prospects for these products.
General Manager, Customer Satisfaction Promotion Section,
TESS Co., Ltd.
CEO, UNIVERSAL SOUND DESIGN Inc.
【Date & Time】 Oct.10(Thu.) 16:00～17:00
In this session, we introduce case study examples for each company covering issues they have faced as startups going global, as well as initiatives designed to overcome these issues, their success stories, and more. Through panel discussions, we will also discover key points to working on a global scale. As befits a global session, this session will be carried out in English.
Chairman and CEO, HEALIOS K.K.
Hardy TS Kagimoto
Representative Director and President,
SanBio Company Limited
Chairman and CEO, HEALIOS K.K.
Hardy TS Kagimoto
Director of Business Development,
Braizon Therapeutics, Inc.
Support of the Core Clinical Research Hospitals for Venture Companies
【Date & Time】 Oct.11(Fri.) 10:30～12:00
This session is part of the efforts of the Project of Translational & Clinical Research Core Centers by Japan’s Ministry of Health, Labour and Welfare, Ministry of Education, Culture, Sports, Science and Technology and Agency for Medical Research and Development (AMED). Core clinical research hospitals are aimed at supporting medical ventures by providing medical evaluations (e.g., advice based on clinical needs and in the clinical context) and clinical research support functions (e.g., protocol development, regulatory consultation and cooperation for clinical trials). In this session, actual examples of this support system will be presented to encourage the use of the core clinical research hospitals in the research and development of venture seeds and to discuss the roles of healthcare facilities in supporting venture businesses.
Stanford University, Byers Center for Biodesign
Program Director (U.S.) Japan Biodesign
Japan Agency for Medical Research and Development (AMED)
【Date & Time】 Oct.11(Fri.) 13:00～14:10
ME-BYO is a project developed by Kanagawa Prefectural Government to promote the awareness of and venture businesses for the presymptomatic state of disease, mibyo. The present session will explore case examples of mibyo businesses, transition from disease treatment to mibyo treatment, concurrent approaches to diseases and mibyo and tackling mibyo through regenerative medicine. Detailed background information and future challenges will be discussed.
Director of ME-BYO industry,
Kanagawa Prefectual Government Healthcare
New Frontier Promotion Headquarters Office,Policy Bureau
Founder, Venex Co.,Ltd.
President, Shisei Datum Ltd.
President & CEO, Human Life CORD Inc.